According to market research study published by Gen Consulting Company, the market size of the global drug delivery devices sector is expected to rise by USD 140.0 billion with a CAGR of 7.4% by the end of 2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global drug delivery devices market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the drug delivery devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the route of administration, application, end user, and region. The global market for drug delivery devices can be segmented by route of administration: injectable, topical, ocular, others. The injectable segment captured the largest share of the market in 2021. Drug delivery devices market is further segmented by application: cancer, cardiovascular, diabetes, infectious disease, others. The diabetes segment held the largest share of the global drug delivery devices market in 2021 and is anticipated to hold its share during the forecast period. Based on end user, the drug delivery devices market is segmented into: hospital, ambulatory surgical center, others. In 2021, the ambulatory surgical center segment made up the largest share of revenue generated by the drug delivery devices market. On the basis of region, the drug delivery devices market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2021.

Market Segmentation
By route of administration: injectable, topical, ocular, others
By application: cancer, cardiovascular, diabetes, infectious disease, others
By end user: hospital, ambulatory surgical center, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global drug delivery devices market report offers detailed information on several market vendors, including Antares Pharma Inc., Bayer AG, Becton, Dickinson and Company, BIOCORP, GlaxoSmithKline plc, Johnson and Johnson, Merck Group, Molex LLC, Novartis AG, Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services Inc, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global drug delivery devices market.
– To classify and forecast the global drug delivery devices market based on route of administration, application, end user, region.
– To identify drivers and challenges for the global drug delivery devices market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global drug delivery devices market.
– To identify and analyze the profile of leading players operating in the global drug delivery devices market.

Why Choose This Report
– Gain a reliable outlook of the global drug delivery devices market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.